00:35:32 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Bristol Myers Squibb to Participate in the 2023 UBS BioPharma Conference

2023-11-02 06:59 ET - News Release


Company Website: http://www.bms.com
PRINCETON, N.J. -- (Business Wire)

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the 2023 UBS BioPharma Conference in Miami Beach, Florida, on Wednesday, November 8, 2023. Lynelle Hoch, president, cell therapy organization, will answer questions about the company during a fireside chat at 8:00 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session here. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

Contacts:

For more information:

Media:
media@bms.com

Investors:
investor.relations@bms.com

Source: Bristol Myers Squibb

© 2024 Canjex Publishing Ltd. All rights reserved.